Accelerating Drug Discovery: Vivodyne’s Andrei Georgescu

2025-07-23

In this episode, we speak with Andrei Georgescu, Co-Founder and CEO of Vivodyne, a biotechnology company accelerating drug discovery by testing treatments on lab-grown 3D human tissues. Andrei co-founded Vivodyne in 2020 after recognizing the limitations of animal testing in predicting human outcomes. He brings deep expertise in tissue engineering, robotics, and AI, with prior work that includes sending lab-grown tissues into space with NASA and developing DNA synthesis chips. Vivodyne’s p...

In this episode, we speak with Andrei Georgescu, Co-Founder and CEO of Vivodyne, a biotechnology company accelerating drug discovery by testing treatments on lab-grown 3D human tissues.

Andrei co-founded Vivodyne in 2020 after recognizing the limitations of animal testing in predicting human outcomes. He brings deep expertise in tissue engineering, robotics, and AI, with prior work that includes sending lab-grown tissues into space with NASA and developing DNA synthesis chips.

Vivodyne’s platform integrates human tissue engineering, scalable robotics, and advanced machine learning to generate predictive human data, reshaping the future of drug development.

I am your host RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.

Comments (3)